7MV-33004-33101 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-16
Dose 1 — Moderna
2021-04-13
Registered in v-safe
2021-04-13
Dose 2 — Moderna
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-14
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-04-15
Survey response — days 1–6 daily, dose 2
MedDRA: Syncope — Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea, Vomiting · Be unable to work

Free text: Fainting

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-15
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

no matching call case
2021-04-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-16	Moderna
2	2021-04-13	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2021-04-14	priority 2/3

1 report(s) with no call case — see the timeline.

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-15

Systemic reaction (other): Fainting

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Syncope	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release